<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/7704</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-8190</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Синдром диабетической стопы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Diabetic foot</subject></subj-group></article-categories><title-group><article-title>Оценка клинико-морфологических особенностей заживления язвенных дефектов при синдроме диабетической стопы</article-title><trans-title-group xml:lang="en"><trans-title>Clinical and morphological characteristics of wound healing in diabetic foot syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0798-0139</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комелягина</surname><given-names>Елена Юрьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Komelyagina</surname><given-names>Elena Yur'evna</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, заведующая отделением диабетической стопы</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">komelelena@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коган</surname><given-names>Евгения Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Kogan</surname><given-names>Eugenia Alexandrovna</given-names></name></name-alternatives><bio xml:lang="ru"><p>профессор, д.м.н., заведующая кафедрой патологической анатомии</p><p> </p></bio><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><email xlink:type="simple">koganevg@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9944-2997</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анциферов</surname><given-names>Михаил Борисович</given-names></name><name name-style="western" xml:lang="en"><surname>Antsiferov</surname><given-names>Mikhail Borisovich</given-names></name></name-alternatives><bio xml:lang="ru"><p>профессор, д.м.н., главный врач</p></bio><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><email xlink:type="simple">antsiferov@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;ГБУЗ Эндокринологический диспансер Департамента здравоохранения города Москвы&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;State Moscow Endocrine Dispensary&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>&lt;p&gt;ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский университет)&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;I.M.Sechenov First Moscow State Medical University&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2017</year></pub-date><volume>20</volume><issue>2</issue><fpage>135</fpage><lpage>141</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Комелягина Е.Ю., Коган Е.А., Анциферов М.Б., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Комелягина Е.Ю., Коган Е.А., Анциферов М.Б.</copyright-holder><copyright-holder xml:lang="en">Komelyagina E.Y., Kogan E.A., Antsiferov M.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/8190">https://www.dia-endojournals.ru/jour/article/view/8190</self-uri><abstract><sec><title>Цель</title><p>Цель. Провести сравнительную оценку клинико-морфологических параметров заживших и незаживших нейропатических язвенных дефектов при синдроме диабетической стопы (СДС).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Были проанализированы 43 образца раневых дефектов при СДС, которые в зависимости от исхода течения заживления раны были разделены на две группы: группа 1 – биоптаты ран, заживших самостоятельно (n=30), группа 2 – биоптаты ран, не заживших самостоятельно (n=13). Анализировались следующие параметры: пол, возраст, уровень HbA1c, длительность существования раны, своевременность обращения за специализированной медицинской помощью, степень выраженности диабетической периферической полинейропатии, наличие поздних осложнений сахарного диабета (СД), плантарная локализация раны, соотношение грануляционной ткани, некроза, фиброза, степень экспрессии Ki 67.</p></sec><sec><title>Результаты</title><p>Результаты. Пациенты обеих групп не отличались по возрасту, уровню HbA1c, степени выраженности поздних осложнений СД, плантарной локализации ран. Статистически значимые отличия получены по следующим параметрам: скорость обращения за специализированной медицинской помощью [50 vs 132 (дня), p=0,03]; наличие грануляционной ткани [61±25 vs 32±21 (%), р=0,001], фиброза [24±24 vs 49±22 (%), р=0,002], грануляции/фиброз [7,5±8,1 vs 1,9±4,6 (%), р=0,02], степень экспрессии Ki67 [15±8 vs 5±6 (%), р=0,001]. В условиях одновременного влияния на заживление раны множества параметров основным являлся показатель содержания грануляций. Если их количество превышало 50%, то вероятность заживления составляла 1.0. Если грануляций содержалось менее 50%, то прогноз заживления определялся экспрессией Ki67. При уровне Ki67&gt;7% вероятность заживления раны составляла 0,75, при уровне Ki67≤7% вероятность заживления составляла 0,17, а незаживления – 0,83.</p></sec><sec><title>Заключение</title><p>Заключение. В условиях оказания специализированной помощи больным с СДС основным показателем, влияющим на прогноз заживления раны, являлась своевременность обращения больного за специализированной помощью. В многомерной модели заживления ключевым параметром являлось количество грануляционной ткани. При содержании грануляций в ране менее 50% прогноз определяется уровнем экспрессии Ki67.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To assess the clinical and morphological characteristics of neuropathic diabetic foot ulcers (DFUn)</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. Forty-three specimens of DFUn were analysed. Depending on the outcome, samples were divided into 2 groups: group 1—healed ulcers (30 samples), group 2—unhealed ulcers (13 samples). The following characteristics were analysed: age, sex, glycated haemoglobin (HbA1c), ulcer duration, time of admission to the specialised clinic, severity of neuropathy, presence of late complications, plantar localisation, percentage of necrotic tissue, granulation and fibrotic tissue and, Ki-67expression.</p></sec><sec><title>Results</title><p>Results. Patients were similar in age, HbA1c, severity of late complications and plantar localisation. There was a significant difference in the time of admission to the specialised clinic [50 vs 132 days, p = 0.03], percentage of granulation [61 ± 25 vs 32 ± 21 %, р = 0.001] and fibrotic tissue [24 ± 24 vs 49 ± 22 %, р = 0.002], the granulation/fibrosis coefficient [7.5 ± 8.1 vs 1.9 ± 4.6 (%), р = 0,02] and expression of Ki-67 [15 ± 8 vs ± 21 (%), р = 0.001] between groups. A multidimensional model revealed granulation tissue as the main parameter influencing healing. The probability of healing was 1.0 if the percentage of granulation tissue was &lt;50%. If the percentage of granulation tissue was &lt;50%, the prognosis of healing was determined by the expression of Ki-67. When Ki-67 levels were &gt;7%, the probability of healing was 0.75. For Ki-67 levels ≤7%, the probability of healing was 0.17 and the probability of not healing was 0.83.</p></sec><sec><title>Conclusion</title><p>Conclusion. The time at which a patient was admitted to the specialised clinic and the percentage of granulation tissue were key factors affecting the prognosis of wound healing in DFUn.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>синдром диабетической стопы</kwd><kwd>предикторы заживления язвенных дефектов</kwd><kwd>грануляции</kwd><kwd>фиброз</kwd><kwd>некроз</kwd><kwd>Ki67</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>diabetic foot syndrom</kwd><kwd>predictors of neuropathic diabetic foot ulcers healing</kwd><kwd>granulation tissue</kwd><kwd>fibrosis</kwd><kwd>Ki67</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">нет</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Международное соглашение по диабетической стопе. – М.: «Берег»; 2000. [Mezhdunarodnoe soglashenie po diabeticheskoy stope. Moscow: «Bereg»; 2000. (in Russ)]</mixed-citation><mixed-citation xml:lang="en">Международное соглашение по диабетической стопе. – М.: «Берег»; 2000. [Mezhdunarodnoe soglashenie po diabeticheskoy stope. Moscow: «Bereg»; 2000. (in Russ)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Галстян Г.Р., Токмакова А.Ю., Егорова Д.Н., и др. Клинические рекомендации по диагностике и лечению синдрома диабетической стопы. // Раны и раневые инфекции. Журнал им. проф. Б.М. Костючёнка. – 2015. – Т. 2. – №3 – С. 63-84. [Galstyan GR, Tokmakova AYu, Egorova DN, et al. Clinical guidelines for diagnosis and treatment of diabetic foot syndrome. Wounds and wound infections the prof. B.M. Kostyuchenok Journal. 2015;2(3):63-84. (in Russ)]</mixed-citation><mixed-citation xml:lang="en">Галстян Г.Р., Токмакова А.Ю., Егорова Д.Н., и др. Клинические рекомендации по диагностике и лечению синдрома диабетической стопы. // Раны и раневые инфекции. Журнал им. проф. Б.М. Костючёнка. – 2015. – Т. 2. – №3 – С. 63-84. [Galstyan GR, Tokmakova AYu, Egorova DN, et al. Clinical guidelines for diagnosis and treatment of diabetic foot syndrome. Wounds and wound infections the prof. B.M. Kostyuchenok Journal. 2015;2(3):63-84. (in Russ)]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Prompers L, Huijberts M, Apelqvist J, et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med. 2008;25(6):700-707. doi: 10.1111/j.1464-5491.2008.02445.x</mixed-citation><mixed-citation xml:lang="en">Prompers L, Huijberts M, Apelqvist J, et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med. 2008;25(6):700-707. doi: 10.1111/j.1464-5491.2008.02445.x</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Комелягина Е.Ю., Анциферов М.Б., Волковой А.К., и др. Факторы, влияющие на заживление язвенных дефектов и его сроки при синдроме диабетической стопы. // Эндокринология. Новости. Мнения. Обучение. – 2016. – Т. 14. – №1. – С. 73- 80. [Komelyagina EYu, Antsiferov MB, Volkovoy AK. Factors affecting time of ulcers healing in diabetic foot patients. Endokrinologiya. Novosti. Mneniya. Obuchenie. 2016;14(1):73-80.(in Russ)]</mixed-citation><mixed-citation xml:lang="en">Комелягина Е.Ю., Анциферов М.Б., Волковой А.К., и др. Факторы, влияющие на заживление язвенных дефектов и его сроки при синдроме диабетической стопы. // Эндокринология. Новости. Мнения. Обучение. – 2016. – Т. 14. – №1. – С. 73- 80. [Komelyagina EYu, Antsiferov MB, Volkovoy AK. Factors affecting time of ulcers healing in diabetic foot patients. Endokrinologiya. Novosti. Mneniya. Obuchenie. 2016;14(1):73-80.(in Russ)]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Medicine. 1998;15(6):508-514. doi: 10.1002/(sici)1096-9136(199806)15:6&lt;508::aid-dia613&gt;3.0.co;2-l</mixed-citation><mixed-citation xml:lang="en">Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Medicine. 1998;15(6):508-514. doi: 10.1002/(sici)1096-9136(199806)15:6&lt;508::aid-dia613&gt;3.0.co;2-l</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tallis A, Motley TA, Wunderlich RP, et al. Clinical and economic assessment of diabetic foot ulcer debridement with collagenase: results of a randomized controlled study. Clin Ther. 2013;35(11):1805-1820. doi: 10.1016/j.clinthera.2013.09.013</mixed-citation><mixed-citation xml:lang="en">Tallis A, Motley TA, Wunderlich RP, et al. Clinical and economic assessment of diabetic foot ulcer debridement with collagenase: results of a randomized controlled study. Clin Ther. 2013;35(11):1805-1820. doi: 10.1016/j.clinthera.2013.09.013</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Комелягина Е.Ю., Коган Е.А., Анциферов М.Б. Клинико-морфологические параметры и маркеры репарации нейропатических язвенных дефектов при синдроме диабетической стопы // Сахарный диабет. – 2015. – Т. 18. – №3. – C. 70-76. [Komelyagina EY, Kogan EA, Antsiferov MB. Clinical and morphological characteristics with markers of reparation in neuropathic diabetic foot ulcers. Diabetes mellitus. 2015;18(3):70-76. (in Russ)]. doi: 10.14341/DM2015370-76</mixed-citation><mixed-citation xml:lang="en">Комелягина Е.Ю., Коган Е.А., Анциферов М.Б. Клинико-морфологические параметры и маркеры репарации нейропатических язвенных дефектов при синдроме диабетической стопы // Сахарный диабет. – 2015. – Т. 18. – №3. – C. 70-76. [Komelyagina EY, Kogan EA, Antsiferov MB. Clinical and morphological characteristics with markers of reparation in neuropathic diabetic foot ulcers. Diabetes mellitus. 2015;18(3):70-76. (in Russ)]. doi: 10.14341/DM2015370-76</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sheehan P, Jones P, Caselli A, et al. Percent Change in Wound Area of Diabetic Foot Ulcers Over a 4-Week Period Is a Robust Predictor of Complete Healing in a 12-Week Prospective Trial. Diabetes Care. 2003;26(6):1879-1882. doi: 10.2337/diacare.26.6.1879</mixed-citation><mixed-citation xml:lang="en">Sheehan P, Jones P, Caselli A, et al. Percent Change in Wound Area of Diabetic Foot Ulcers Over a 4-Week Period Is a Robust Predictor of Complete Healing in a 12-Week Prospective Trial. Diabetes Care. 2003;26(6):1879-1882. doi: 10.2337/diacare.26.6.1879</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51(5):747-755. doi: 10.1007/s00125-008-0940-0</mixed-citation><mixed-citation xml:lang="en">Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51(5):747-755. doi: 10.1007/s00125-008-0940-0</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Beckert S, Witte M, Wicke C, et al. A New Wound-Based Severity Score for Diabetic Foot Ulcers: A prospective analysis of 1,000 patients. Diabetes Care. 2006;29(5):988-992. doi: 10.2337/dc05-2431</mixed-citation><mixed-citation xml:lang="en">Beckert S, Witte M, Wicke C, et al. A New Wound-Based Severity Score for Diabetic Foot Ulcers: A prospective analysis of 1,000 patients. Diabetes Care. 2006;29(5):988-992. doi: 10.2337/dc05-2431</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care. 2006;29(8):1784-1787. doi: 10.2337/dc06-0306</mixed-citation><mixed-citation xml:lang="en">Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care. 2006;29(8):1784-1787. doi: 10.2337/dc06-0306</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Комелягина Е.Ю., Волковой А.К., Сабанчиева Н.И., и др. Междисциплинарный подход к ведению больных с синдромом диабетической стопы. // Клиническая медицина. – 2016. – Т.94. – №2. – С.127-132. [Komelyagina EYu, Volkovoy AK, Sanbanchieva NI, et al. Multidisciplinary team approach for diabetic foot patients in an out-patient clinic. Klinicheskaya meditsina. 2016;94(2):127-132. (in Russ)]</mixed-citation><mixed-citation xml:lang="en">Комелягина Е.Ю., Волковой А.К., Сабанчиева Н.И., и др. Междисциплинарный подход к ведению больных с синдромом диабетической стопы. // Клиническая медицина. – 2016. – Т.94. – №2. – С.127-132. [Komelyagina EYu, Volkovoy AK, Sanbanchieva NI, et al. Multidisciplinary team approach for diabetic foot patients in an out-patient clinic. Klinicheskaya meditsina. 2016;94(2):127-132. (in Russ)]</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Frykberg RG, Banks J. Challenges in the Treatment of Chronic Wounds. Adv Wound Care (New Rochelle). 2015;4(9):560-582. doi: 10.1089/wound.2015.0635</mixed-citation><mixed-citation xml:lang="en">Frykberg RG, Banks J. Challenges in the Treatment of Chronic Wounds. Adv Wound Care (New Rochelle). 2015;4(9):560-582. doi: 10.1089/wound.2015.0635</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-Montequin JI, Valenzuela-Silva CM, Diaz OG, et al. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study. Int Wound J. 2009;6(6):432-443. doi: 10.1111/j.1742-481X.2009.00641.x</mixed-citation><mixed-citation xml:lang="en">Fernandez-Montequin JI, Valenzuela-Silva CM, Diaz OG, et al. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study. Int Wound J. 2009;6(6):432-443. doi: 10.1111/j.1742-481X.2009.00641.x</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
